Global Pharmaceuticals & Biotech Healthy potentially undervalued

High Tide

Market Cap: CA$292.6m

Engages in the cannabis retail business in Canada, the United States, and internationally.

Trulieve Cannabis

Market Cap: US$1.9b

Operates as a cannabis retailer in the United States.

CorMedix

Market Cap: US$636.8m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

Hypera

Market Cap: R$14.6b

Operates as a pharmaceutical company in Brazil.

Green Thumb Industries

Market Cap: CA$2.2b

Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.

Supernus Pharmaceuticals

Market Cap: US$2.8b

A biopharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States.

Elanco Animal Health

Market Cap: US$11.8b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Yunnan Baiyao GroupLtd

Market Cap: CN¥89.6b

Engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China.

Hugel

Market Cap: ₩2.7t

Develops and manufactures biopharmaceuticals in South Korea and internationally.

UCB

Market Cap: €41.5b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

Prestige Consumer Healthcare

Market Cap: US$2.4b

Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.

Bavarian Nordic

Market Cap: DKK 14.8b

Develops, manufactures, and supplies life-saving vaccines.

Dong-E-E-Jiao

Market Cap: CN¥32.9b

Engages in the research, development, production, and sale of donkey-hide gelatin and related products in China and internationally.

Diaceutics

Market Cap: UK£121.4m

A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.

Virbac

Market Cap: €2.8b

Manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Pacific.

Cresco Labs

Market Cap: CA$470.3m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.

Journey Medical

Market Cap: US$188.0m

A commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

Decibel Cannabis

Market Cap: CA$66.4m

An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.

Fennec Pharmaceuticals

Market Cap: US$416.2m

Operates as a commercial stage biopharmaceutical company in the United States.

Duopharma Biotech Berhad

Market Cap: RM 1.2b

Researches, develops, manufactures, markets, sells, imports, and distributes pharmaceutical products and medicines in Malaysia and internationally.

Dong-A ST

Market Cap: ₩364.3b

Develops, manufactures, and markets pharmaceutical products in South Korea and internationally.

Amoy Diagnostics

Market Cap: CN¥7.6b

Engages in research and development, production, sale, and supporting services of tumor precision medical diagnostic products in China and internationally.

China Resources Pharmaceutical Group

Market Cap: HK$30.7b

An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.

Dermapharm Holding

Market Cap: €2.0b

Manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China.

Daewoong Pharmaceutical

Market Cap: ₩1.4t

Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.

Laboratorios Farmaceuticos Rovi

Market Cap: €3.1b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

Viatris

Market Cap: US$18.6b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Verastem

Market Cap: US$672.9m

A development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States.

Amphastar Pharmaceuticals

Market Cap: US$907.8m

A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.

Vanda Pharmaceuticals

Market Cap: US$328.9m

A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.

Curaleaf Holdings

Market Cap: CA$3.4b

Engages in the retail and wholesale of cannabis products in the United States and internationally.

TG Therapeutics

Market Cap: US$7.1b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

Zevra Therapeutics

Market Cap: US$687.1m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

ADMA Biologics

Market Cap: US$2.1b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Exelixis

Market Cap: US$13.2b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Protara Therapeutics

Market Cap: US$235.2m

A clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.